Grifols

Developer of plasma-derived therapies to treat multiple diseases

placeBarcelona, Catalonia, Spain calendar_todayFounded 1909 groups18,309 employees language grifols.com

Web presence

Audience by country — top 5 markets by share of visits.

CountryShare
United States62.6%
Spain21%
Canada2.9%
United Kingdom2.4%
India1.8%

Social engagement

Social engagement: 313.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital120%
Private equity240%
Other / undisclosed240%

Share of voice

Share of voice in Spain: 100% of web traffic across its competitive set; worldwide: 4.4%.

Recent activity

23 Jun 2026
Recognition
22 Jun 2026
Product launch
Evanzys IH
16 Jun 2026
Recognition
Coming soon